PAREXEL Los Angeles

Specialties

Located on the Glendale Adventist Medical Center campus, this clinical unit has been managed by PAREXEL since 2006 and hosts 75 early phase research beds.

The unit is staffed around the clock by a highly trained and certified team, which includes board-​certified physicians in psychiatry and internal medicine as well as Members and Fellows of the American College of Cardiology and the American College of Physicians. The staff consists of clinical pharmacologists, pharmacists, registered nurses, licensed vocational nurses, and clinical research coordinators, research associates, and a recreational therapist.

The unit offers participants a safe and comfortable environment for medical care.

Features include:

* Flat screen TVs and WiFi at each bed

* Large recreation room that includes computers, games, and more

* Dining room

The Los Angeles unit specializes in studies with volunteers of the following descents:

* Armenian

* Chinese

* Japanese

* Korean

* Hispanic

In addition to healthy volunteer studies, PAREXEL runs studies for patients diagnosed with the following conditions:

* Alzheimer’s Disease

* Depression

* Mild Cognitive Impairment and Memory Loss

* Parkinson’s Disease

* Schizophrenia or Schizoaffective Disorder

* Stroke

History

Established in 1982.

PAREXEL is a leading biopharmaceutical services organization with more than 30 years’ experience helping clients bring their new treatments to patients faster through our drug development and launch services.

We have relationships with most of the world’s top pharmaceutical and biotechnology companies, and also provide services to the growing sector of smaller biotechnology, pharmaceutical and medical device companies.

PAREXEL has participated in the development of 19 of the world’s top 20 prescription drugs and operates with the highest ethical and scientific standards.

PAREXEL currently has over 15,000 employees in 80 locations throughout 51 countries. PAREXEL also operates EPCUs in Baltimore, MD, Berlin, Germany, London, U.K. and Bloemfontein, South Africa.